Most Recent
A judge has rejected a bid by Bellamy's to limit the recoverable costs of rival law firms running joint class actions against the baby food maker, saying he would deal with any unjustified duplication later, not now.
A leading female partner at Piper Alderman, who is suing the firm's other partners for sex discrimination, has told a court their attempt to oust her from the partnership was based on groundless claims of bullying and was a case of "skulduggery".
AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic.
Unilever is not ready to put its long-running consumer case against competitor Beiersdorf to rest, filing a challenge to a ruling that Beiersdorf did not make misleading claims about its Nivea clinical strength deodorant products.
Clive Palmer has lost a bid to overturn an order freezing more than $200 million in his personal assets in a case brought by the liquidators of collapsed Queensland Nickel.
Ramsay Health Care has denied its conduct towards a group of surgeons seeking to open a rival clinic in Coffs Harbour, NSW was anti-competitive or a misuse of market power, telling the court on the first day of trial that the venture was doomed to fail.
A five-member appeals panel in the NSW Supreme Court has overturned former NSW Labor Minister for Mineral Resources Ian Macdonald's conviction for wilful misconduct of public office in relation to the Doyles Creek Mining scandal.
A damages battle in an infringement case over two patents for the ubiquitous plastic produce containers found in grocery stores across Australia is over, with the fight settling ahead of a hearing.
Pitcher Partners just found another reason to challenge a ruling that it owes $5.6 million in damages for concealing an accounting error from a client -- a ruling that socks it with $3.3 million in legal costs for its "deceit".
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".